Skip to main content
. Author manuscript; available in PMC: 2024 Mar 21.
Published in final edited form as: Travel Med Infect Dis. 2017 May 6;17:50–55. doi: 10.1016/j.tmaid.2017.05.003

Table 5.

Numbers of respondents in each exposure group, and in sensitivity analysis.

Antimalarial type Any Prolonged Prolonged-exclusive
Exposed Unexposed Exposed Unexposed Exposed Unexposed
Mefloquine 3401 5530 2070 5530 1734 5494
Chloroquine 715 8216 215 8216 190 7869
Doxycycline 1743 7188 1015 7188 708 7123
Atovaquone-proguanil 429 8502 249 8502 173 8206